[{"country": "United States", "city": "Chadds Ford", "address_1": "100 Endo Blvd", "reason_for_recall": "Adulterated Presence of Foreign Tablets: Customer complaint that some Endocet 10 mg/325 mg tablets were found mixed in a bottle with Endocet 10 mg/650 mg tablets.", "address_2": "", "product_quantity": "11,764 bottles", "code_info": "Lot #: 402794NV, Exp 12/13", "center_classification_date": "20120614", "distribution_pattern": "Nationwide and Puerto Rico", "state": "PA", "product_description": "Endocet (oxycodone and acetaminophen) tablets, USP, 10 mg/650 mg, 100-count tablets per bottle, Rx only, Manufactured for: Endo Pharmaceuticals Inc., Chadds Ford, PA, By: Novartis, Lincoln, NE  68501; NDC 60951-797-70.", "report_date": "20120620", "classification": "Class III", "openfda": {}, "recalling_firm": "Endo Pharmaceuticals, Inc.", "recall_number": "D-1381-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "61791", "termination_date": "20130621", "more_code_info": "", "recall_initiation_date": "20120507", "postal_code": "19317", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA020309"], "brand_name": ["MAGNESIUM SULFATE IN WATER"], "generic_name": ["MAGNESIUM SULFATE IN WATER"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-2050", "0409-6730", "0409-6729", "0409-4121", "0409-3164", "0409-5239"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["MAGNESIUM SULFATE HEPTAHYDRATE"], "rxcui": ["829734", "1658259", "1658262", "1658264", "1658265"], "spl_id": ["7c96de7c-c75b-487c-8534-0b0b2de9cdea"], "spl_set_id": ["22ca78b4-f5a3-4144-cf89-5f633acf1e6d"], "package_ndc": ["0409-6730-11", "0409-6730-13", "0409-6730-50", "0409-6730-60", "0409-6729-41", "0409-6729-23", "0409-6729-21", "0409-6729-03", "0409-6729-31", "0409-6729-09", "0409-6729-11", "0409-6729-24", "0409-4121-01", "0409-4121-50", "0409-2050-01", "0409-2050-20", "0409-3164-01", "0409-3164-12", "0409-5239-01", "0409-5239-60"], "is_original_packager": [true], "unii": ["SK47B8698T"]}, "product_type": "Drugs", "event_id": "62053", "recalling_firm": "Hospira, Inc.", "address_1": "600 N Field Dr Bldg J45", "address_2": "N/A", "postal_code": "60045", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1390-2012", "product_description": "Magnesium Sulfate in Water for Injection, 40 mg/mL (0.325 mEq Mg++/mL), 2 g total, 50 mL Flexible Container, Rx only, Hospira, Inc., Lake Forest, IL 60045; NDC 0409-6729-24.", "product_quantity": "164,568 containers", "reason_for_recall": "Superpotent (Single Ingredient) Drug: Above specification assay results for percentage of magnesium sulfate.", "recall_initiation_date": "20120405", "center_classification_date": "20120620", "termination_date": "20130808", "report_date": "20120627", "code_info": "Lot #: 04510KL*, Exp 01OCT2012; *lot number may have 01 or 02 following it"}, {"country": "United States", "city": "Tulsa", "address_1": "12515 E 55th St Ste 100", "reason_for_recall": "Tablet Separation: The manufacturer of Arthrotec had recalled the lots that were used to re-package this product because they may contain broken tablets.", "address_2": "", "product_quantity": "a) 4 bottles; b) 2 bottles", "code_info": "Lot #: a) 5NON, Exp 04/13; 5YUN, Exp 09/13; b) 5KBJ, Exp 02/13; 5LVX, Exp 04/13", "center_classification_date": "20120614", "distribution_pattern": "NC and KY", "state": "OK", "product_description": "Arthrotec 75 (diclofenac sodium and misoprostol) tablets, 75 mg/200 mcg, a) 30-count tablets per bottle (NDC 54868-4165-1); b) 60-count tablets per bottle (NDC 54868-4165-0); Rx only, Mfg. By: G.D. searle LLC Div Pfizer, New York, NY  10017; Repacked & distributed by: Physicians total Care, Inc., Tulsa, OK  74146.", "report_date": "20120620", "classification": "Class II", "openfda": {}, "recalling_firm": "Physicians Total Care, Inc.", "recall_number": "D-1379-2012", "initial_firm_notification": "FAX", "product_type": "Drugs", "event_id": "62135", "termination_date": "20130222", "more_code_info": "", "recall_initiation_date": "20110919", "postal_code": "74146-6234", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Abbott Park", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020819"], "brand_name": ["ZEMPLAR"], "generic_name": ["PARICALCITOL"], "manufacturer_name": ["AbbVie Inc."], "product_ndc": ["0074-1658", "0074-4637"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["PARICALCITOL"], "rxcui": ["200321", "213298", "352076", "1736919", "1736921", "1736931"], "spl_id": ["378ff0fd-3d1d-4834-a5cb-85673c60a643"], "spl_set_id": ["7259652f-81bc-4ad1-bba5-d01f9fac1b80"], "package_ndc": ["0074-4637-01", "0074-1658-01", "0074-1658-05"], "is_original_packager": [true], "nui": ["M0007651", "N0000175907", "N0000175849"], "pharm_class_cs": ["Ergocalciferols [CS]"], "pharm_class_epc": ["Vitamin D2 Analog [EPC]", "Vitamin D Analog [EPC]"], "unii": ["6702D36OG5"]}, "product_type": "Drugs", "event_id": "61878", "recalling_firm": "Abbott Laboratories", "address_1": "100 Abbott Park Rd", "address_2": "N/A", "postal_code": "60064-3502", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1388-2012", "product_description": "Zemplar (paricalcitol) Injection, 5 mcg/mL in 2 mL multi-dose vials, 25 vial carton, Rx only, Manufactured by Hospira, Inc. For Abbott Laboratories, North Chicago, IL 60064, USA, NDC 0074-1658-05", "product_quantity": "121,000 vials", "reason_for_recall": "CGMP Deviations: There is potential that Abbott's third party manufacturer, Hospira, may have applied a foreign (incorrect) stopper to vials in a specific lot of Zemplar Injection.", "recall_initiation_date": "20120514", "center_classification_date": "20120618", "termination_date": "20121203", "report_date": "20120627", "code_info": "Lot #: 11-122-DK, Exp 10/13"}, {"country": "United States", "city": "Garland", "address_1": "3309 W Kingsley Rd", "reason_for_recall": "Subpotent (Single Ingredient Drug): The firm is recalling the product because the product is subpotent and does not meet the labeled 0.25% zinc pyrithione level.", "address_2": "", "product_quantity": "4800 bottles", "code_info": "Lot 022110-01", "center_classification_date": "20120614", "distribution_pattern": "Maine", "state": "TX", "product_description": "DermaZinc Spray, 0.25% zinc pyritione, topical  OTC, 4 fl oz bottle Distributed By: Dermallogix Partners, Inc. Scarborough, ME 04070", "report_date": "20120620", "classification": "Class III", "openfda": {}, "recalling_firm": "Quadrant Chemical Corporation", "recall_number": "D-1380-2012", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "61518", "termination_date": "20120913", "more_code_info": "", "recall_initiation_date": "20120320", "postal_code": "75041-2207", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Miami", "address_1": "11960 Sw 144th St", "reason_for_recall": "Miscalibrated and/or Defective Delivery System: Out of Specification results for mechanical peel force and/or the z-statistic value which relates to the patient's ability to remove the release liner from the patch adhesive prior to administration.", "address_2": "", "product_quantity": "244,320 patches", "code_info": "Lot #: 43783, Exp 01/12", "center_classification_date": "20120614", "distribution_pattern": "Nationwide and Puerto Rico.", "state": "FL", "product_description": "Daytrana (methylphenidate) transdermal system patch, Delivers 15 mg over 9 hours (1.6 mg/hr), 1 patch per pouch (NDC 54092-553-01), packaged in 30-count patches per box (NDC 54092-553-30), Rx only, Manufactured for Shire US Inc., Wayne, PA  19087; by Noven Pharmaceuticals, Inc., Miami, FL  33186.", "report_date": "20120620", "classification": "Class II", "openfda": {}, "recalling_firm": "Noven Pharmaceuticals, Inc.", "recall_number": "D-1374-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "61891", "termination_date": "20130523", "more_code_info": "", "recall_initiation_date": "20110705", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Tulsa", "state": "OK", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "61233", "recalling_firm": "Physicians Total Care, Inc", "address_1": "12515 E 55th St Ste 100", "address_2": "N/A", "postal_code": "74146-6234", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "FAX", "distribution_pattern": "FL", "recall_number": "D-1385-2012", "product_description": "Morphine Sulfate Extended Release tablet, 30 mg, 60 tablet bottles, Rx only, Physician Total Care, Inc, Tulsa, Ok 74146-6234, NDC 54868-4033-00", "product_quantity": "540 tablets (9 containers of 60 tablets each)", "reason_for_recall": "Labeling: Label mix-up; Bottles labeled to contain Morphine Sulfate IR may contain Morphine Sulfate ER and vice-versa.", "recall_initiation_date": "20101110", "center_classification_date": "20120618", "termination_date": "20120724", "report_date": "20120627", "code_info": "PTC Drug Number: 4033.  PTC Batch Number: 65IT.  Batch Date: 10/13/2010.  Expiration Date: 11/30/2011.  NDC: 54868-4033-00"}, {"status": "Terminated", "city": "Saint Louis", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020124"], "brand_name": ["DIAZEPAM"], "generic_name": ["DIAZEPAM"], "manufacturer_name": ["Meridian Medical Technologies LLC"], "product_ndc": ["11704-600"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["DIAZEPAM"], "rxcui": ["1807452"], "spl_id": ["9e08d47f-b706-44b2-9e2f-9ca972592050"], "spl_set_id": ["fa352464-14c8-49e9-b8b7-5a968b1cfa93"], "package_ndc": ["11704-600-01"], "is_original_packager": [true], "upc": ["0311704600015"], "nui": ["N0000175694", "M0002356"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_cs": ["Benzodiazepines [CS]"], "unii": ["Q3JTX2Q7TU"]}, "product_type": "Drugs", "event_id": "62015", "recalling_firm": "Meridian Medical Technologies a Pfizer Company", "address_1": "1945 Craig Rd", "address_2": "", "postal_code": "63146-4105", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide, military, Italy, Singapore, Sweden, and Canada.", "recall_number": "D-1369-2012", "product_description": "Diazepam Injection, USP, 10 mg Automatic, Autoinjector for Buddy Use, 5 mg/mL, 2 mL autoinjector, 15-count autoinjectors per carton, Rx only, Meridian Medical Technologies, Columbia, MD  21046; A subsidiary of King Pharmaceuticals, Inc.; NSN 6505-01-274-0951, NDC 11704-600-01.", "product_quantity": "83,400 autoinjectors", "reason_for_recall": "Impurities/Degradation Products: High Out of Specification levels for carbostyril, a known degradation product of diazepam.", "recall_initiation_date": "20120606", "center_classification_date": "20120611", "termination_date": "20130805", "report_date": "20120620", "code_info": "Lot #: 8D1082, Exp 01/13; 8D1151, Exp 03/13", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077908"], "brand_name": ["PROPOFOL"], "generic_name": ["PROPOFOL"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-4699", "0409-6010"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["PROPOFOL"], "rxcui": ["1808217", "1808222", "1808224"], "spl_id": ["d55c0318-811d-4624-aa0c-456182f7b019"], "spl_set_id": ["28d7ba00-f824-4e55-139a-03f509c099db"], "package_ndc": ["0409-4699-50", "0409-4699-30", "0409-4699-53", "0409-4699-33", "0409-4699-54", "0409-4699-24", "0409-6010-02", "0409-6010-25"], "is_original_packager": [true], "nui": ["N0000175975", "N0000175681"], "pharm_class_pe": ["General Anesthesia [PE]"], "pharm_class_epc": ["General Anesthetic [EPC]"], "unii": ["YI7VU623SF"]}, "product_type": "Drugs", "event_id": "62009", "recalling_firm": "Hospira, Inc.", "address_1": "600 N Field Dr Bldg J45", "address_2": "", "postal_code": "60045", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1382-2012", "product_description": "Propofol Injectable Emulsion, 1%, (10mg/mL), packaged in a) 200 mg/20 mL, 5 Units x 20 mL Single patient infusion vials per carton (NDC 0409-4699-30); b) 1 g/100 mL, 10 Units x 100 mL Single patient infusion vials per carton (NDC 0409-4699-24); Rx only, Hospira, Inc., Lake Forest, IL 60045, USA.", "product_quantity": "a) 36,125 vials; b) 31,280 vials", "reason_for_recall": "Presence of Particulate Matter: A single visible particulate was observed in a retention sample bottles identified as stainless steel", "recall_initiation_date": "20120411", "center_classification_date": "20120614", "termination_date": "20130627", "report_date": "20120620", "code_info": "Lot #: a) 03440DJ*, Exp 1MAR2013; b) 07947DJ, Exp 1JUL2013; 10134DJ, Exp 1OCT2013;  Note: * the lot may be followed by 01.", "more_code_info": ""}, {"status": "Terminated", "city": "Tulsa", "state": "OK", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "61233", "recalling_firm": "Physicians Total Care, Inc", "address_1": "12515 E 55th St Ste 100", "address_2": "N/A", "postal_code": "74146-6234", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "FAX", "distribution_pattern": "FL", "recall_number": "D-1386-2012", "product_description": "Morphine Sulfate Immediate Release tablet, 30 mg/120 tablet bottles, Rx only,   Physician Total Care, Inc, Tulsa, OK 74146-6234, NDC 54868-4973-00", "product_quantity": "600 tablets (5 containers of 120 tablets each)", "reason_for_recall": "Labeling: Label mix-up; Bottles labeled to contain Morphine Sulfate IR may contain Morphine Sulfate ER and vice-versa.", "recall_initiation_date": "20101110", "center_classification_date": "20120618", "termination_date": "20120724", "report_date": "20120627", "code_info": "PTC Drug Number: 4973.  PTC Batch Number: 65J2.  Batch Date: 10/13/2010.  Expiration Date: 06/30/2012.  NDC: 54868-4973-00"}, {"country": "United States", "city": "Bedford", "address_1": "300 Northfield Rd", "reason_for_recall": "Short Fill: These products are being recalled because there is potential that vials with low fill volume were released into distribution.", "address_2": "", "product_quantity": "6,515 packs", "code_info": "Lot # 2006500, Exp 08/31/12", "center_classification_date": "20120614", "distribution_pattern": "Nationwide and Puerto Rico.", "state": "OH", "product_description": "Octreotide Acetate Injection, 50 mcg/mL (0.05 mg/mL), 1 mL single dose vials, packaged in 10 x 1 mL single dose vials per pack, Rx only, Manufactured for: Bedford Laboratories, Bedford, OH  44146; Manufactured by: Ben Venue Laboratories, Inc., Bedford, OH  44146; NDC 55390-160-10; UPC 3 55390-160-10 1.", "report_date": "20120620", "classification": "Class II", "openfda": {}, "recalling_firm": "Ben Venue Laboratories Inc", "recall_number": "D-1377-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "61802", "termination_date": "20130821", "more_code_info": "", "recall_initiation_date": "20120501", "postal_code": "44146", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Shirley", "address_1": "One Luitpold Drive", "reason_for_recall": "Presence of Particulate Matter:  In the course of inspecting retention samples visual particles were observed.", "address_2": "P.O. Box 9001", "product_quantity": "30 mL: 2,078,800 vials; 100 mL: 167,100 vials", "code_info": "30 mL  Lots: 9198, 9252, 9299, 9305, 9402, 9423,  9432, 9553, 9595, 9646, 9681, 9737, 9797, 9831, 0051, 0095,  0362;    100 mL  Lots: 9225, 9492, 9711, 0007, 0058", "center_classification_date": "20120614", "distribution_pattern": "Nationwide, Puerto Rico, and Abu Dhabi", "state": "NY", "product_description": "CONCENTRATED SODIUM CHLORIDE INJECTION, USP, 23.4%  a) 30 mL SINGLE DOSE VIAL,  (NDC 0517-2930-25), b) 100 mL PHARMACY BULK PACKAGE (NDC 0517-2900-25), Rx Only, AMERICAN REGENT, INC. SHIRLEY, NY 11967.", "report_date": "20120620", "classification": "Class II", "openfda": {}, "recalling_firm": "Luitpold Pharmaceuticals, Inc.", "recall_number": "D-1378-2012", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "58410", "termination_date": "20180628", "more_code_info": "", "recall_initiation_date": "20110315", "postal_code": "11967-9001", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Tampa", "address_1": "8500 Hidden River Pkwy", "reason_for_recall": "Lack of Assurance of Sterility: Bausch & Lomb, Inc. is recalling 7 Lots of Murocel Methylcellulose Lubricant Opthalmic Solution 1% (15 mL).  Product was found to be OOS for Antimicrobial Effectiveness testing (AET) at the 12 month stability time point.", "address_2": "", "product_quantity": "59,777 bottles", "code_info": "Lot#: 467061, Exp 09/11; 487551, Exp 11/11; 507521, Exp 1/12; 548051, Exp 5/12; 132171, Exp 8/12; 136571, Exp 11/12; 140181, Exp 1/13.", "center_classification_date": "20120611", "distribution_pattern": "Nationwide", "state": "FL", "product_description": "Murocel (methylcellulose) Lubricant Opthalmic Solution (USP, 1%), 15 mL bottle, OTC, Manufactured by Bausch & Lomb Incorporated, Tampa, FL 33637, NDC 24208-280-15", "report_date": "20120620", "classification": "Class II", "openfda": {}, "recalling_firm": "Bausch & Lomb, Inc.", "recall_number": "D-1370-2012", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "61964", "termination_date": "20120924", "more_code_info": "", "recall_initiation_date": "20110706", "postal_code": "33637-1014", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Tulsa", "state": "OK", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62239", "recalling_firm": "Physicians Total Care, Inc.", "address_1": "12515 E 55th St Ste 100", "address_2": "N/A", "postal_code": "74146-6234", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "FAX", "distribution_pattern": "AK, NC, GA", "recall_number": "D-1389-2012", "product_description": "Lipitor (Atorvastatin calcium); 40 mg, 30 TABLETS, Rx only, Repacked & distributed: Physicians Total Care, Inc., Tulsa OK 74146, NDC 54868-4229-0", "product_quantity": "3 bottles", "reason_for_recall": "Chemical Contamination: Complaints of an uncharacteristic odor identified as 2,4,6 tribromoanisole.", "recall_initiation_date": "20120208", "center_classification_date": "20120619", "termination_date": "20120705", "report_date": "20120627", "code_info": "Lots 6284, 60DI, 61AA."}, {"country": "United States", "city": "Radnor", "address_1": "259 N Radnor Chester Rd", "reason_for_recall": "Impurities/Degradation Products: Out Of Specification levels of nitrogen dioxide.", "address_2": "", "product_quantity": "123 cylinders", "code_info": "Lot #: YA02Z087A, YA02Z087B, YA02Z087C, YA02Z087D, YA02Z087E, YA02Z087F, Exp 03/27/17; YA022088A, YA022088B, YA022088C, YA022088D, YA022088E, YA022088F, YA022088G, YK01Z088A, YK01Z088B, YK01Z088C, YK01Z088D, YK01Z088E, YK01Z088F, YK01Z088G, Exp 03/28/17; YA02Z089A, YA02Z089B, YK01Z089A, YK01Z089B, Exp 03/29/17", "center_classification_date": "20120612", "distribution_pattern": "Medical facilities in AZ and CA.", "state": "PA", "product_description": "Carbon Dioxide, USP, Medical Gas, packaged in a) size EA aluminum, CGA940 (CDUSPEA), b) size E CGA 940 (CDUSPE),  c) 50 lb CGA320 (CDUSP50, CD USP50S), d) size 160 liter (CD USP160LT350) cylinders, Rx only, Airgas, Puritan Medical, Distributed By: Airgas USA, LLC, Radnor, PA.", "report_date": "20120620", "classification": "Class II", "openfda": {}, "recalling_firm": "Airgas Inc", "recall_number": "D-1371-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "61947", "termination_date": "20130322", "more_code_info": "", "recall_initiation_date": "20120410", "postal_code": "19087-5240", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3", "54092-554-30"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "61891", "recalling_firm": "Noven Pharmaceuticals, Inc.", "address_1": "11960 Sw 144th St", "address_2": "", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico.", "recall_number": "D-1372-2012", "product_description": "Daytrana (methylphenidate) transdermal system patch, Delivers 20 mg over 9 hours (2.2 mg/hr), 1 patch per pouch, packaged in 30-count patches per box, Rx only, labeled as a) Manufactured for Shire US Inc., Wayne, PA 19087 by Noven Pharmaceuticals, Inc., Miami, FL 33186; NDC 54092-554-30; b) Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, By Noven Pharmaceuticals, Inc., Miami, FL 33186; NDC 68968-5554-3.", "product_quantity": "357,510 patches", "reason_for_recall": "Miscalibrated and/or Defective Delivery System: Out of Specification results for mechanical peel force and/or the z-statistic value which relates to the patient's ability to remove the release liner from the patch adhesive prior to administration.", "recall_initiation_date": "20110705", "center_classification_date": "20120614", "termination_date": "20130523", "report_date": "20120620", "code_info": "Lot #'s: a) 49203, Exp 10/12; b) 50265, Exp 01/13", "more_code_info": ""}, {"country": "United States", "city": "Miami", "address_1": "11960 Sw 144th St", "reason_for_recall": "Miscalibrated and/or Defective Delivery System: Out of Specification results for mechanical peel force and/or the z-statistic value which relates to the patient's ability to remove the release liner from the patch adhesive prior to administration.", "address_2": "", "product_quantity": "335,190 patches", "code_info": "Lot #: 41843, Exp 11/11", "center_classification_date": "20120614", "distribution_pattern": "Nationwide and Puerto Rico.", "state": "FL", "product_description": "Daytrana (methylphenidate) transdermal system patch, Delivers 10 mg over 9 hours (1.1 mg/hr), 1 patch per pouch (NDC 54092-552-01), packaged in 30-count patches per box (NDC 54092-552-30), Rx only, Manufactured for Shire US Inc., Wayne, PA  19087; by Noven Pharmaceuticals, Inc., Miami, FL  33186.", "report_date": "20120620", "classification": "Class II", "openfda": {}, "recalling_firm": "Noven Pharmaceuticals, Inc.", "recall_number": "D-1375-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "61891", "termination_date": "20130523", "more_code_info": "", "recall_initiation_date": "20110705", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Bedford", "address_1": "300 Northfield Rd", "reason_for_recall": "Short Fill: These products are being recalled because there is potential that vials with low fill volume were released into distribution.", "address_2": "", "product_quantity": "11,161 packs", "code_info": "Lot #1856177, Exp 06/30/13", "center_classification_date": "20120614", "distribution_pattern": "Nationwide and Puerto Rico.", "state": "OH", "product_description": "Midazolam HCl Injection, 5 mg/mL, 1 mL single use vials, packaged in 10 x 1 mL single use vials per pack, Rx only, Manufactured by: Ben Venue Laboratories, Inc., Bedford, OH  44146; Manufactured for: Bedford Laboratories, Bedford, OH  44146, NDC 55390-138-01; UPC 3 55390-138-01 8.", "report_date": "20120620", "classification": "Class II", "openfda": {}, "recalling_firm": "Ben Venue Laboratories Inc", "recall_number": "D-1376-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "61802", "termination_date": "20130821", "more_code_info": "", "recall_initiation_date": "20120501", "postal_code": "44146", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Cincinnati", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "61960", "recalling_firm": "Kutol Products Co Inc", "address_1": "7650 Camargo Rd", "address_2": "N/A", "postal_code": "45243-3108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "IL", "recall_number": "D-1387-2012", "product_description": "Hands Down Medicated Lotion Soap, 1 gallon bottle, 4 gallons per case, Distributed by PCS Industries, Crestwood, IL, 60446", "product_quantity": "11,688 gallon bottles (2,922 cases)", "reason_for_recall": "Labeling: Presence of Undeclared Additive: Medicated lotion soap produced and distributed by the recalling firm contains the unapproved ingredient, Red Dye #15.  This dye is not approved for use in food, drugs or cosmetics.", "recall_initiation_date": "20120521", "center_classification_date": "20120618", "termination_date": "20121204", "report_date": "20120627", "code_info": "Lot #: 090204012 , 090303026 , 090508009 , 090604024 , 090725030 , 090829002, 091005017 , 091223002 , 100115022 , 100316005 , 100115022 , 100316005,100329004 , 100607017 , 100730001 , 100817014 , 100921018 , 101020009, 101208003 , 101218007 , 110405009 , (L)11053105 , (L)11062811 , (L)11081805, and (L)11091206"}, {"status": "Terminated", "city": "Sellersville", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA021544"], "brand_name": ["JOLESSA"], "generic_name": ["LEVONORGESTREL / ETHINYL ESTRADIOL"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0555-9123"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["238019", "748797", "751901", "762663"], "spl_id": ["aaf5797d-3069-42ba-a8d2-088e5cd33b2c"], "spl_set_id": ["f1076019-6f2c-4c90-9f3c-ab0c7cdd9315"], "package_ndc": ["0555-9123-66"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "61759", "recalling_firm": "Teva Pharmaceuticals USA, Inc.", "address_1": "650 Cathill Rd", "address_2": "N/A", "postal_code": "18960-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1384-2012", "product_description": "Jolessa (levonorgestrel/ethinyl estradiol tablets, USP) 0.15 mg/0.03 mg, each Dispenser contains 91 tablets, 91 Day Regimen, Rx Only, Shaping Women's Health, Manufactured by: Barr Laboratories, Inc., Pomona, NY 10970, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0555-9123-66.", "product_quantity": "40,750 Dispensers", "reason_for_recall": "Contraceptive Tablets Out of Sequence: This recall has been initiated due to the potential that some regimen packages may not contain placebo tablets.", "recall_initiation_date": "20120423", "center_classification_date": "20120619", "termination_date": "20130423", "report_date": "20120627", "code_info": "Lot #'s 33801826A, Exp 1/2013; 33802144A; 33802323A, Exp 3/2013; 33802519A, Exp 6/2013"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "61917", "recalling_firm": "Linde Gas LLC", "address_1": "7029 Huntley Rd Ste K", "address_2": "N/A", "postal_code": "43229-1059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Distributed only within Ohio.  No Federal Government, foreign or Canadian consignees received product.", "recall_number": "D-1383-2012", "product_description": "LifeGas OXYGEN COMPRESSED UN1072 USP,   Distributed by: Linde", "product_quantity": "283 cylinders", "reason_for_recall": "CGMP Deviations: The pressure gages, vacuum gages, and thermometer had surpassed the calibration expiry period, which may have resulted in overfill/underfill of oxygen cylinders.", "recall_initiation_date": "20120504", "center_classification_date": "20120615", "termination_date": "20130611", "report_date": "20120627", "code_info": "LOT#: 117H201  LOT#: 117H202"}, {"country": "United States", "city": "Miami", "address_1": "11960 Sw 144th St", "reason_for_recall": "Miscalibrated and/or Defective Delivery System: Out of Specification results for mechanical peel force and/or the z-statistic value which relates to the patient's ability to remove the release liner from the patch adhesive prior to administration.", "address_2": "", "product_quantity": "242,100 patches", "code_info": "Lot #: 43008, Exp 01/12; 48591, Exp 10/12", "center_classification_date": "20120614", "distribution_pattern": "Nationwide and Puerto Rico.", "state": "FL", "product_description": "Daytrana (methylphenidate) transdermal system patch, Delivers 30 mg over 9 hours (3.3 mg/hr), 1 patch per pouch (NDC 54092-555-01), packaged in 30-count patches per box (NDC 54092-555-30), Rx only, Manufactured for Shire US Inc., Wayne, PA 19087 by Noven Pharmaceuticals, Inc., Miami, FL 33186.", "report_date": "20120620", "classification": "Class II", "openfda": {}, "recalling_firm": "Noven Pharmaceuticals, Inc.", "recall_number": "D-1373-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "61891", "termination_date": "20130523", "more_code_info": "", "recall_initiation_date": "20110705", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}]